EXACTUSS TOTAL RELEASE

Product NDC
58552-327
11-digit product format
585520327
Labeler code
58552
Product ID
58552-327_c9d5b39b-b35a-3d82-e053-2995a90adb5f
Type
HUMAN OTC DRUG
Nonproprietary name
Guaifenesin, Dextromethorphan HBr, and Phenylephrine HCl
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Gil Pharmaceutical Corp
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2009-10-19
Marketing end
0000-00-00
Substance
PHENYLEPHRINE HYDROCHLORIDE; GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE
Active strength
10 mg/1; mg/1; mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
58552-327-012025-06-26C16284748780-1f386c649-f4ca-0266-e053-dadaa90a7c1aa854de22-2f90-48c9-8cde-98446f7958b9
58552-327-012023-01-30C16284748780-1f386c649-f4ca-0266-e053-dadaa90a7c1aa854de22-2f90-48c9-8cde-98446f7958b9

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DEXTROMETHORPHAN HYDROBROMIDEACTIVE INGREDIENT9D2RTI9KYHGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
GUAIFENESINACTIVE INGREDIENT495W7451VQGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
DEXTROMETHORPHANACTIVE MOIETY7355X3ROTSGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
GUAIFENESINACTIVE MOIETY495W7451VQGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEINACTIVE INGREDIENTO7TSZ97GEPGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48GILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
HYPROMELLOSE 2910 (6 MPA.S)INACTIVE INGREDIENT0WZ8WG20P6GILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
MAGNESIUM SILICATEINACTIVE INGREDIENT9B9691B2N9GILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30GILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
MINERAL OILINACTIVE INGREDIENTT5L8T28FGPGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
POVIDONE K30INACTIVE INGREDIENTU725QWY32XGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4GILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPGILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2
TRIACETININACTIVE INGREDIENTXHX3C3X673GILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET [GIL PHARMACEUTICAL CORP]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58552-327GILTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET, FILM COATED EXACTUSS TOTAL RELEASE (GUAIFENESIN, DEXTROMETHORPHAN HBR, AND PHENYLEPHRINE HCL) TABLET, FILM COATED [GIL PHARMACEUTICAL CORP]5Legacy NDC20210819_a854de22-2f90-48c9-8cde-98446f7958b9.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
58552-327-0158552032701100 TABLET, FILM COATED in 1 BOTTLE (58552-327-01) 2011-05-270000-00-00NoNoCurrent